• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec4
Decheng Capital Reduced Legend Biotech Stock Holdings in Q2
10:21
Nov21
IvyRock Increases Stake in Legend Biotech
14:16
Nov19
Johnson & Johnson and Legend Biotech Withdraw Carvykti's Clinical Data Comparison Study with Competitors
11:37
Nov13
Cantor Fitzgerald Analyst Reiterates Buy Rating on Legend Biotech
13:42
Nov12
William Blair Analyst Maintains Hold Rating on Legend Biotech
20:17
Legend Biotech released FY2025 Q3 earnings on November 12 Pre-Market EST, actual revenue USD 272.33 M (forecast USD 275.4 M), actual EPS USD -0.22 (forecast USD -0.1092)
14:30

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 272.33 M, Net Income -39.69 M, EPS -0.2199

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 255.06 M, Net Income -125.38 M, EPS -0.6809

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 195.05 M, Net Income -100.92 M, EPS -0.5491

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
GURE
8.896
+87.69%
+4.120
SMX
256.300
+81.77%
+127.000
WHLR
5.782
+78.47%
+2.610
PAVS
0.0481
+52.70%
+0.017
JFBR
3.630
+45.20%
+1.120
TDIC
0.3973
+41.49%
+0.112
PRAX
246.355
+29.68%
+57.628
TORO
5.220
+26.40%
+1.075
RBRK
87.270
+23.91%
+16.980
BMEA
1.436
+20.67%
+0.238
View More